126 related articles for article (PubMed ID: 36995894)
1. In-depth proteomic signature of parathyroid carcinoma.
Kong SH; Lee JH; Bae JM; Hong N; Kim H; Park SY; Choi YJ; Lee S; Rhee Y; Kim SW; Han D; Kim JH; Shin CS
Eur J Endocrinol; 2023 Apr; 188(4):385-394. PubMed ID: 36995894
[TBL] [Abstract][Full Text] [Related]
2. Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality.
Kong SH; Bae JM; Kim JH; Kim SW; Han D; Shin CS
Endocrinol Metab (Seoul); 2024 Apr; 39(2):375-386. PubMed ID: 38509667
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis.
Ciregia F; Cetani F; Pardi E; Soggiu A; Piras C; Zallocco L; Borsari S; Ronci M; Caruso V; Marcocci C; Mazzoni MR; Lucacchini A; Giusti L
Cancer Genomics Proteomics; 2021; 18(6):781-796. PubMed ID: 34697069
[TBL] [Abstract][Full Text] [Related]
4. Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas.
Wang O; Wang C; Nie M; Cui Q; Guan H; Jiang Y; Li M; Xia W; Meng X; Xing X
PLoS One; 2012; 7(9):e45567. PubMed ID: 23029104
[TBL] [Abstract][Full Text] [Related]
5. A proteomic approach to study parathyroid glands.
Giusti L; Cetani F; Ciregia F; Da Valle Y; Donadio E; Giannaccini G; Banti C; Pardi E; Saponaro F; Basolo F; Berti P; Miccoli P; Pinchera A; Marcocci C; Lucacchini A
Mol Biosyst; 2011 Mar; 7(3):687-99. PubMed ID: 21180715
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of preoperative predictive factors and clinical characteristics in patients with parathyroid carcinoma].
Yao XA; Jiang T; Wei BB; Chang H
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):428-432. PubMed ID: 29936768
[No Abstract] [Full Text] [Related]
7. Genome-wide analysis of differentially expressed lncRNA in sporadic parathyroid tumors.
Jiang T; Wei BJ; Zhang DX; Li L; Qiao GL; Yao XA; Chen ZW; Liu X; Du XY
Osteoporos Int; 2019 Jul; 30(7):1511-1519. PubMed ID: 30972448
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT.
Pyo JS; Cho WJ
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30926677
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.
Ozolins A; Narbuts Z; Vanags A; Simtniece Z; Visnevska Z; Akca A; Wirowski D; Gardovskis J; Strumfa I; Goretzki PE
Langenbecks Arch Surg; 2016 Nov; 401(7):943-951. PubMed ID: 26658808
[TBL] [Abstract][Full Text] [Related]
10. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.
Silva-Figueroa AM; Bassett R; Christakis I; Moreno P; Clarke CN; Busaidy NL; Grubbs EG; Lee JE; Perrier ND; Williams MD
Endocr Pathol; 2019 Dec; 30(4):285-296. PubMed ID: 31734935
[TBL] [Abstract][Full Text] [Related]
11. Relationship of AgNOR counts and nuclear DNA content to survival in patients with parathyroid carcinoma.
Lumachi F; Ermani M; Marino F; Poletti A; Basso SM; Iacobone M; Favia G
Endocr Relat Cancer; 2004 Sep; 11(3):563-9. PubMed ID: 15369455
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_0005729 enhances accuracy in diagnosing parathyroid carcinoma.
Wang Q; Wang J; Xin Y; He Z; Zhou X; Liu X; Zhao T; He L; Shen H; Jin M; Wei B
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35029546
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases.
Bergero N; De Pompa R; Sacerdote C; Gasparri G; Volante M; Bussolati G; Papotti M
Hum Pathol; 2005 Aug; 36(8):908-14. PubMed ID: 16112008
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma.
Schneider R; Bartsch-Herzog S; Ramaswamy A; Bartsch DK; Karakas E
World J Surg; 2015 Oct; 39(10):2477-83. PubMed ID: 26154578
[TBL] [Abstract][Full Text] [Related]
15. Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients.
Xue S; Chen H; Lv C; Shen X; Ding J; Liu J; Chen X
Clin Endocrinol (Oxf); 2016 Jul; 85(1):29-36. PubMed ID: 26939543
[TBL] [Abstract][Full Text] [Related]
16. Expression profile of serum-related exosomal miRNAs from parathyroid tumor.
Wang J; Wang Q; Zhao T; Liu X; Bai G; Xin Y; Shen H; Wei B
Endocrine; 2021 Apr; 72(1):239-248. PubMed ID: 33161496
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomics analysis of sporadic parathyroid adenoma tissue samples.
Arya AK; Bhadada SK; Singh P; Dahiya D; Kaur G; Sharma S; Saikia UN; Behera A; Rao SD; Bhasin M
J Endocrinol Invest; 2019 May; 42(5):577-590. PubMed ID: 30284223
[TBL] [Abstract][Full Text] [Related]
18. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors.
Wang O; Wang CY; Shi J; Nie M; Xia WB; Li M; Jiang Y; Guan H; Meng XW; Xing XP
Chin Med J (Engl); 2012 Aug; 125(16):2895-901. PubMed ID: 22932087
[TBL] [Abstract][Full Text] [Related]
19. Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism.
Bae JH; Choi HJ; Lee Y; Moon MK; Park YJ; Shin CS; Park DJ; Jang HC; Kim SY; Kim SW
J Korean Med Sci; 2012 Aug; 27(8):890-5. PubMed ID: 22876055
[TBL] [Abstract][Full Text] [Related]
20. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
Al-Maghrabi JA; Asa SL
Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
